Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Synonyms||OMP313M32|OMP 313M32|OMP-313M32|WHO 10742|
Etigilimab (OMP-313M32) is an anti-human TIGIT (T cell immunoreceptor with Ig ITIM domain) antibody that potentially has anti-tumor activities through modulating the immune response to tumors (AACR, Vol 58, April 2017, Abstract #599, PMID: 31874056).
|DrugClasses||Immune Checkpoint Inhibitor 146 TIGIT Antibody 14|
|CAS Registry Number||2044984-83-8|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|Etigilimab + Nivolumab||Etigilimab Nivolumab||0||2|